Epidemiological and clinical profile of leprosy patients at a tertiary care center in Moradabad: a retrospective study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20262734Keywords:
Disability, Epidemiology, Lepra reaction, Leprosy, Multidrug therapy, Multibacillary leprosyAbstract
Background: Leprosy remains an important public health challenge in India despite achieving elimination status at the national level. Delayed diagnosis contributes to disability, deformity and continued transmission. This study assessed the epidemiological and clinical profile of leprosy patients attending a tertiary care center in Moradabad, Uttar Pradesh.
Methods: A retrospective record-based study was conducted among 186 clinically diagnosed leprosy patients attending the Department of Dermatology, Venereology and Leprology of a tertiary care teaching hospital over a two-year period. Data regarding demographic characteristics, clinical features, nerve involvement, disease classification, bacteriological status, lepra reactions, disability grading, treatment status and outcomes were analyzed using SPSS version 25.0.
Results: Most patients belonged to the 21–40 years age group (43.6%) and were from lower socioeconomic and educational backgrounds. The mean duration of symptoms was 11.8±7.4 months. Peripheral nerve involvement was observed in 78.5% of patients and sensory loss in 90.3%. Multibacillary disease accounted for 59.1% of cases and slit-skin smear positivity was observed in 59.1%. Lepra reactions occurred in 29.0% of patients, predominantly Type I reactions. Grade 0 disability was present in 58.1% of patients, while visible deformities were identified in 17.2%, with claw hand being the most common deformity. Most patients were receiving multidrug therapy and 69.9% demonstrated clinical improvement.
Conclusions: The predominance of multibacillary disease, extensive nerve involvement and disability suggests delayed diagnosis and ongoing transmission. Strengthening early case detection, public awareness, surveillance and treatment adherence may reduce disability and improve leprosy control outcomes.
References
Agrawal N, Saha TR, Barua JK, Banerjee G, Chatterjee K, Halder S, et al. Clinico-epidemiological study of leprosy in a tertiary care hospital of Eastern India. Int J Res Dermatol. 2023;9:96-102.
Karotia D, Kishore J, Kumar A. Epidemiological determinants of leprosy in a high endemic district of India: A community based case control study. Indian J Lepr. 2022;94:69-80.
Singal A, Sonthalia S. Leprosy in post-elimination era in India: Difficult journey ahead. Indian J Dermatol. 2013;58:443-6.
Geetharani G, Pavithra G, Sathesh P. Clinico epidemiological study of untreated multibacillary leprosy patients visiting a tertiary care hospital in Madurai. Indian J Lepr. 2018;90:197-206.
Adil M, Amin SS, Mohtashim M, Mushtaq S, Alam M, Priya A. Clinico-epidemiological study of leprosy from a North Indian tertiary care hospital. Int J Res Dermatol. 2018;4:518-21.
Jindal N, Shanker V, Tegta GR, Gupta M, Verma GK. Clinico-epidemiological trends of leprosy in Himachal Pradesh: a five-year study. Indian J Lepr. 2009;81:173-9.
Gupta R, Sinha R, Pradhan S. Clinico-epidemiological profile of leprosy in post-elimination era: a hospital-based study. Indian J Lepr. 2019;91:197-205.
Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: an open, retrospective analysis of institutional records. An Bras Dermatol. 2020;95:52-56.
Kurup R, Haynes U, Mentore G. A study on trends and patterns of leprosy in Guyana during a ten-year period, 2007–2016. Indian J Lepr. 2018;90:207-16.
Tiwary PK, Kar HK, Sharma PK. Epidemiological trends of leprosy in an urban leprosy centre of Delhi: a retrospective study of 16 years. Indian J Lepr. 2011;83:201-8.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7.
IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. Armonk (NY): IBM Corp.; 2017.
Mahajan VK, Sharma NL, Rana P. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study. Indian J Lepr. 2003;75:17-24.
Singh AL, Vagha SJ, Agarwal A. Current scenario of leprosy at tertiary care level hospital of rural central India. Indian J Dermatol Venereol Leprol. 2009;75:520-2.
Sonkar VK. A clinico-epidemiological study of leprosy in a tertiary care centre. Int J Curr Adv Res. 2018;7:14350-53.
Bishnoi S, Verma A, Nijhawan M, Bagri M, Nijhawan S, Sharma A. Leprosy. Gulf J Dermatol Venereol. 2019;26:1-5.
Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. National Leprosy Eradication Programme (NLEP): Revised classification and treatment protocol effective April 1, 2025. New Delhi: Ministry of Health and Family Welfare. 2025.
Polycarpou A, Walker SL, Lockwood DNJ. New findings in the pathogenesis of leprosy and implications for the management of leprosy. Curr Opin Infect Dis. 2013;26:413-9.
Pandey A. Current perspectives on leprosy as a public health challenge in India. Res Rep Trop Med. 2015;6:43-8.
Talhari S, Grossi MA, Oliveira MLW, Gontijo B, Talhari C, Penna GO. Hansen's disease: a vanishing disease. Mem Inst Oswaldo Cruz. 2012;107(1):13-6.
Rees RJW, Young DB. The microbiology of leprosy. In: Hastings RC, editor. Leprosy. 2nd ed. New York: Churchill Livingstone. 1994: 49-83.
Downloads
Published
How to Cite
Issue
Section
